209 related articles for article (PubMed ID: 3117625)
1. Increased arachidonic acid composition of phospholipids in colonic mucosa from patients with active ulcerative colitis.
Nishida T; Miwa H; Shigematsu A; Yamamoto M; Iida M; Fujishima M
Gut; 1987 Aug; 28(8):1002-7. PubMed ID: 3117625
[TBL] [Abstract][Full Text] [Related]
2. Increased arachidonic acid levels in phospholipids of human colonic mucosa in inflammatory bowel disease.
Pacheco S; Hillier K; Smith C
Clin Sci (Lond); 1987 Oct; 73(4):361-4. PubMed ID: 3665357
[TBL] [Abstract][Full Text] [Related]
3. Altered colonic mucosal availability of n-3 and n-6 polyunsaturated fatty acids in ulcerative colitis and the relationship to disease activity.
Pearl DS; Masoodi M; Eiden M; Brümmer J; Gullick D; McKeever TM; Whittaker MA; Nitch-Smith H; Brown JF; Shute JK; Mills G; Calder PC; Trebble TM
J Crohns Colitis; 2014 Jan; 8(1):70-9. PubMed ID: 23619007
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
5. Ulcerative colitis--a disease characterised by the abnormal colonic epithelial cell?
Gibson PR; van de Pol E; Barratt PJ; Doe WF
Gut; 1988 Apr; 29(4):516-21. PubMed ID: 3371720
[TBL] [Abstract][Full Text] [Related]
6. Changes in plasma and colonic mucosa fatty acid profiles in rats with ulcerative colitis induced by trinitrobenzene sulfonic acid.
Nieto N; Giron MD; Suarez MD; Gil A
Dig Dis Sci; 1998 Dec; 43(12):2688-95. PubMed ID: 9881501
[TBL] [Abstract][Full Text] [Related]
7. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
Matsuda R; Koide T; Tokoro C; Yamamoto T; Godai T; Morohashi T; Fujita Y; Takahashi D; Kawana I; Suzuki S; Umemura S
Inflamm Bowel Dis; 2009 Mar; 15(3):328-34. PubMed ID: 18942752
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation.
D'Argenio G; Valenti M; Scaglione G; Cosenza V; Sorrentini I; Di Marzo V
FASEB J; 2006 Mar; 20(3):568-70. PubMed ID: 16403786
[TBL] [Abstract][Full Text] [Related]
9. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease.
Sharon P; Stenson WF
Gastroenterology; 1984 Mar; 86(3):453-60. PubMed ID: 6319219
[TBL] [Abstract][Full Text] [Related]
10. Exaggerated prostaglandin production by colonic smooth muscle in rabbit colitis.
Kao HW; Zipser RD
Dig Dis Sci; 1988 Jun; 33(6):697-704. PubMed ID: 3163542
[TBL] [Abstract][Full Text] [Related]
11. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in ulcerative colitis.
Wang YD; Yan PY
World J Gastroenterol; 2006 Oct; 12(37):6050-3. PubMed ID: 17009408
[TBL] [Abstract][Full Text] [Related]
13. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
Griga T; Voigt E; Gretzer B; Brasch F; May B
Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
[TBL] [Abstract][Full Text] [Related]
14. ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides.
Hu X; Deng J; Yu T; Chen S; Ge Y; Zhou Z; Guo Y; Ying H; Zhai Q; Chen Y; Yuan F; Niu Y; Shu W; Chen H; Ma C; Liu Z; Guo F
Gastroenterology; 2019 Mar; 156(4):1098-1111. PubMed ID: 30452920
[TBL] [Abstract][Full Text] [Related]
15. Bactericidal/permeability-increasing protein in colonic mucosa in ulcerative colitis.
Haapamäki MM; Häggblom JO; Grönroos JM; Pekkala E; Alanen K; Nevalainen TJ
Hepatogastroenterology; 1999; 46(28):2273-7. PubMed ID: 10521980
[TBL] [Abstract][Full Text] [Related]
16. Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation.
Goldin E; Karmeli F; Selinger Z; Rachmilewitz D
Dig Dis Sci; 1989 May; 34(5):754-7. PubMed ID: 2469561
[TBL] [Abstract][Full Text] [Related]
17. Altered leukotriene B4 metabolism in colonic mucosa with inflammatory bowel disease.
Ikehata A; Hiwatashi N; Kinouchi Y; Yamazaki H; Ito K; Toyota T
Scand J Gastroenterol; 1995 Jan; 30(1):44-9. PubMed ID: 7701249
[TBL] [Abstract][Full Text] [Related]
18. Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis.
Nieto N; Torres MI; Ríos A; Gil A
J Nutr; 2002 Jan; 132(1):11-9. PubMed ID: 11773501
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA exhibit altered expression in the inflamed colonic mucosa of ulcerative colitis patients.
Valmiki S; Ahuja V; Paul J
World J Gastroenterol; 2017 Aug; 23(29):5324-5332. PubMed ID: 28839432
[TBL] [Abstract][Full Text] [Related]
20. 15-HETE is the main eicosanoid formed by human colonic mucosa.
Zijlstra FJ; van Dijk AP; Wilson JH; van Riemsdijk-Overbeeke IC; Vincent JE; Ouwendijk RJ
Agents Actions; 1992; Spec No():C53-9. PubMed ID: 1442336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
